(Q28610258)

3 February 2017

1 reference

Europe PubMed Central

title

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration (English)

1 reference

3 February 2017

1 reference

1 reference

1 reference

H. A. Chapman

1

1 reference

3 February 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9330876

19 November 2024

publication date

1 October 1997

1 reference

3 February 2017

October 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9330876

full work available at URL

19 November 2024

https://api.elsevier.com/content/article/PII:S0955067497801263?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

https://api.elsevier.com/content/article/PII:S0955067497801263?httpAccept=text/plain

19 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

Current Opinion in Cell Biology

19 November 2024

published in

1 reference

3 February 2017

volume

9

1 reference

3 February 2017

issue

5

1 reference

3 February 2017

page(s)

714–724

1 reference

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

3 February 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Accumulation of Type 1 Plasminogen Activator Inhibitor and Vitronectin at Sites of Cellular Necrosis and Inflammation

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The urokinase receptor is required for human monocyte chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Impaired wound healing in mice with a disrupted plasminogen gene

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency.

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Physiological consequences of loss of plasminogen activator gene function in mice

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Role of enzymes mediating thrombosis and thrombolysis in lung disease

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Generation and characterization of urokinase receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains.

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Plasminogen activation at the cell surface-matrix interface.

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The adaptor protein Shc couples a class of integrins to the control of cell cycle progression

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

7 January 2021

Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles

series ordinal

33

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

19 November 2024

series ordinal

60

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma

19 November 2024

series ordinal

67

1 reference

https://api.crossref.org/works/10.1016/S0955-0674(97)80126-3

19 November 2024

Identifiers

0 references

1 reference